Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Summary

The investigators wish to determine the time to disease progression for benign neurofibromas treated with Levulan Kerastick topical photosensitizer and red light photodynamic therapy (PDT) in patients with neurofibromatosis type 1 (NF1). The investigators also wish to measure tumor size for control and treatment tumors in order to gain insights into tumor growth rates.

Timeline

Start

2016-09-16

Primary completion

2025-12-31

Completion

2026-03-28

Outcome

Outcome not reported

Stopped: “data analysis unequivocal - requires study methodology re-evaluation”

Drugs

Indications